PRINCETON, NJ, July 21 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. invites analysts and investors to participate in a briefing on Wednesday, August 5, with David B. Holtz, Interim President Chief Executive Officer, and Chief Financial Officer, regarding the Company’s 2009 second quarter results.
